Category: Cardiogenic Shock

Abiomed’s Cardiogenic Shock Guidelines

The use of standardized protocols has been associated with improvement in outcomes for people in cardiogenic shock. Such protocols enable clinicians to quickly assess a situation and rapidly decide on next steps. These protocols present Abiomed’s cardiogenic shock guidelines and include best practices to identify, stabilize, revascularize, and reassess high-risk cardiogenic shock patients. Inserting mechanical … Continue reading “Abiomed’s Cardiogenic Shock Guidelines”

Cardiogenic Shock Clinical Dossier

Impella 2.5®, Impella CP®, Impella 5.0®, and Impella LD® heart pumps are now  FDA indicated to provide treatment of ongoing cardiogenic shock. In this setting, the Impella® heart pumps have the ability to stabilize the patient’s hemodynamics, unload the left ventricle, perfuse the end organs, and allow for recovery of the native heart.